Global /South Korea /Healthcare /Drug Manufacturers - General /003090

Daewoong Co., Ltd.

003090

• KRX: 003090 • Delayed

22,550KRW -0.7%

14.46 USD

As of 7 June 2026, Daewoong Co., Ltd. has a market cap of $605.56M USD, ranking #13907 globally and #395 in South Korea. It ranks #1246 in the Healthcare sector, and #460 in the Drug Manufacturers - General industry.

Global Rank

13907

Country Rank

395

Sector Rank

1246

Industry Rank

460

Key Stats

Market Cap

$605.56MUSD

928.22B KRW

Enterprise Value

$1.35BUSD

2.11T KRW

Revenue (TTM)

$1.35BUSD

2.07T KRW

EBITDA (TTM)

$207.32MUSD

323.4B KRW

Net Income (TTM)

$114.21MUSD

175.06B KRW

EBITDA Margin

16%

Profit Margin

8.5%

PE Ratio

5.3

PS Ratio

0.4

PB Ratio

0.5

EV/EBITDA

5.9

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

379

Founded

1945

Website

daewoongholdings.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.7%	-0.2%	-8.2%	-3%	0.9%	3.4%	16%	53%	-39%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	003090 (주)대웅 ISIN: KR7003090008 Shares Out.: Shares Outstanding: 42.037M¹ Shares Float: 26.045M² TV: TradingView: KRX: 003090 SA: Stock Analysis: KRX: 003090 YF: Yahoo Finance: 003090.KS GF: Google Finance: KRX: 003090 BA: Barron's: 003090 MS: Morningstar: XKRX: 003090	22,550 KRW	TV: TradingView: KRX: 003090 SA: Stock Analysis: KRX: 003090 YF: Yahoo Finance: 003090.KS GF: Google Finance: KRX: 003090 BA: Barron's: 003090 MS: Morningstar: XKRX: 003090

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Daewoong Co., Ltd.

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.07B 13.91T KRW 1K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.72B 10.3T KRW 1K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.2B 7.97T KRW 759%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.92B 7.55T KRW 713%	-	South Korea
Yuhan Corp. KRX: 000100	$4.51B 6.92T KRW 646%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.41B 6.76T KRW 628%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 126K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 90K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 59K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 54K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 48K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 46K%	20.5	Switzerland

chevron_leftBack